The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard Therapy

NCT04667975 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
74
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Chong Kun Dang Pharmaceutical

Collaborators